Mega Lifesciences PCL (BKK:MEGA) Ending Cash Position : ฿3,463 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Ending Cash Position?

Mega Lifesciences PCL's Ending Cash Position for the quarter that ended in Dec. 2024 was ฿3,463 Mil.

Mega Lifesciences PCL's quarterly Ending Cash Position declined from Jun. 2024 (฿3,687 Mil) to Sep. 2024 (฿2,909 Mil) but then increased from Sep. 2024 (฿2,909 Mil) to Dec. 2024 (฿3,463 Mil).

Mega Lifesciences PCL's annual Ending Cash Position declined from Dec. 2022 (฿2,453 Mil) to Dec. 2023 (฿2,357 Mil) but then increased from Dec. 2023 (฿2,357 Mil) to Dec. 2024 (฿3,463 Mil).

Mega Lifesciences PCL Ending Cash Position Historical Data

The historical data trend for Mega Lifesciences PCL's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Ending Cash Position Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,006.45

2,197.69

2,453.47

2,356.73

3,462.73

Mega Lifesciences PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															2,356.73	2,968.01	3,687.15	2,909.25	3,462.73

Mega Lifesciences PCL Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mega Lifesciences PCL's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2356.726	+	1106.005
	=	3,463

Mega Lifesciences PCL's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2909.252	+	553.479
	=	3,463

Mega Lifesciences PCL Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MEGA-R:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines